Congenital muscular dystrophy Lamin A/C Myasthenia Gravis MG Biomarkers Biomarker Dystrophin Exercise Cytokines DMD Mechanotransduction RNA interference Myotonic Dystrophy Lamin A/C LMNA gene Thymus Skeletal muscle Long read sequencing Antisense oligonucleotides Mice Astrocyte COVID-19 Cardiomyopathy Myositis Humans AAV Calcium Laminopathies Actin Spinal muscular atrophy Myasthenia gravis FSHD Myotonic dystrophy Outcome measures Aged Aging Fibrosis Autoantibodies Animals Myoblasts Becker muscular dystrophy Cell therapy Errance diagnostique Centronuclear myopathy Heart failure Autoimmunity CMS ALS Amyotrophic lateral sclerosis Laminopathy Neuromuscular disease LMNA gene Motoneuron Neuromuscular junction RNA biology Dynamin 2 Gene therapy CTG repeat contractions Neuromuscular diseases Regeneration Glutamate Thérapie génique Dilated cardiomyopathy Myotonic dystrophy type 1 Muscular dystrophy Muscle regeneration CRISPRi OPMD Satellite cell Duchenne muscular dystrophy Genetics Dermatomyositis Male MBNL Myopathies Satellite cells Rare neuromuscular diseases Laminopathie Transcriptomics Myopathy Autoimmune diseases Trinucleotide repeat expansion Myotonic Dystrophy type 1 Rare diseases Cytoskeleton Nuclear envelope LMNA PABPN1 Inflammation Brain Mouse model Transgenic mouse model Autophagy Congenital myopathy Therapy Myogenesis Alternative splicing Treatment Heart Fabry disease Muscle Genotype phenotype correlation